JEFFREY KAM, M.D.
Pediatric Allergy/Immunology Physician in HONOLULU, Hawaii. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JEFFREY KAM, M.D. reported a CMS MIPS final score of 86.203/100 — above the 83.1 national average — and filed 2,183 Medicare Part D claims in 2023.
- 86.203/100
- MIPS score · +3 vs avg
- 2K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JEFFREY KAM, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
86 Top 48% higher than 52% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
JEFFREY KAM, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about JEFFREY KAM, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Hawaii
How Pediatric Allergy/Immunology Physician compares to other specialties among Hawaii providers
Pediatric Allergy/Immunology Physician share within Hawaii
Pediatric Allergy/Immunology Physician is one of the more visible NUCC categories in Hawaii
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JEFFREY KAM, M.D.'s 2023 MIPS final score plotted against the Pediatric Allergy/Immunology Physician national average
- MIPS Final Score
- 86.203/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Allergy/Immunology Physician) — 86.203/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pediatric Allergy/Immunology Physician US NPIs
86.203/100 MIPS final score — 3.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pediatric Allergy/Immunology Physician. Quality dim: 80.286. Cost dim: 73.7239.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JEFFREY KAM, M.D. appears in the CMS NPPES registry as a Pediatric Allergy/Immunology Physician provider holding M.D. credentials at 888 S KING ST, HONOLULU, HI, 96813, with a listed phone of (808) 522-4310. NPI 1669561841 was issued on 10/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KAM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,183 prescription claims written by this provider, covering 401 Medicare beneficiaries and totaling roughly $570K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.203/100 for the 2023 performance year (Quality 80.286, Cost 73.7239), compared with the national average of 83.1.
Pediatric Allergy/Immunology Physician is a narrow specialty nationwide, with 419 enrolled providers across 43 states and an average of 345 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669561841 |
|---|---|
| Specialty | Pediatric Allergy/Immunology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JEFFREY KAM, M.D.'s current license status, disciplinary history, and board certifications with the Hawaii Medical Board in Hawaii before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where JEFFREY KAM, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 2,183 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,703
- Total Day Supply
- 136,789
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $475K
- Generic Drug Cost
- $96K
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 0.96
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 23, 65-74: 200, 75-84: 145, 85+: 33
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JEFFREY KAM, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ipratropium Bromide
Ipratropium Bromide
333 claims
- Fluticasone Propio…
Fluticasone Propionate
316 claims
- Famotidine
Famotidine
259 claims
- Montelukast Sodium
Montelukast Sodium
256 claims
- Azelastine Hcl
Azelastine Hcl
159 claims
- Levocetirizine Dih… 76
Levocetirizine Dihydrochloride
76 claims
- Prednisone 68
Prednisone
68 claims
- Albuterol Sulfate … 67
Albuterol Sulfate Hfa
67 claims
| Drug | Claims |
|---|---|
| Ipratropium Bromide | 333 |
| Fluticasone Propionate | 316 |
| Famotidine | 259 |
| Montelukast Sodium | 256 |
| Azelastine Hcl | 159 |
| Levocetirizine Dihydrochloride | 76 |
| Prednisone | 68 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 67 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 62 |
| Gabapentin | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Allergy/Immunology Physician Overview
How JEFFREY KAM, M.D. fits within the Pediatric Allergy/Immunology Physician landscape nationally.
JEFFREY KAM, M.D.'s 2,183 claims are above the specialty average of 345.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Hawaii
Frequently Asked Questions
What is JEFFREY KAM, M.D.'s specialty? ▼
How much does JEFFREY KAM, M.D. prescribe under Medicare Part D? ▼
What is JEFFREY KAM, M.D.'s Medicare quality score? ▼
Where is JEFFREY KAM, M.D. located? ▼
What is JEFFREY KAM, M.D.'s NPI number? ▼
Does JEFFREY KAM, M.D. prescribe more brand-name or generic drugs? ▼
How many Pediatric Allergy/Immunology Physician providers are there in the US? ▼
What drugs does JEFFREY KAM, M.D. prescribe most often? ▼
Does JEFFREY KAM, M.D. accept Medicare? ▼
How can I verify JEFFREY KAM, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology